查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589796

馬藥品和補充品市場：按產品和分銷管道 - 2025 年至 2030 年全球預測

Equine Pharmaceuticals & Supplements Market by Product (Pharmaceutical, Supplement), Distribution Channel (Drug Stores, Veterinary Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，馬匹藥品和補充品市場價值為93052萬美元，預計到2024年將達到98349萬美元，複合年成長率為5.78%，到2030年將達到137952萬美元。

馬匹藥品和補充品市場包括各種專用馬匹配製的產品，包括旨在維持和促進馬匹健康的藥品、營養補充品和獸醫治療。這些產品的需求主要源自於馬匹廣泛參與需要最佳健康和表現的運動、農業和休閒活動。其用途範圍從提供必需營養素、管理關節和骨骼健康到治療特定的醫療狀況。獸醫、馬治療師、飼養員和馬主是主要的最終用戶，這凸顯了這些產品對馬業的重要性。市場成長受到諸如馬健康意識增強、馬疾病患病率上升以及對天然成分和配方的日益偏好等因素的強烈影響。此外，馬術運動產業的擴張也為市場需求提供了重要動力。然而，市場面臨原料成本波動、嚴格的監管環境以及需要進行全面研究來檢驗產品有效性等挑戰。該領域的創新可以集中於開發先進的補充品輸送系統、利用生物技術進步進行新穎的治療，以及利用資料分析進行個人化的馬匹健康管理。也可以研究和開發專門針對特定品種或病理狀況的製劑。進入這一領域的公司應考慮建立策略夥伴關係和聯盟，以加強分銷並擴大產品線以瞄準利基市場。馬術運動蓬勃發展的開拓領域存在潛在商機，企業需要製定有效的市場滲透和消費者教育策略。該市場是成熟公司和新興企業公司的所在地，創造了一個需要持續技術創新和對品質承諾的競爭環境。儘管面臨挑戰，但在對專業和永續解決方案的持續需求的推動下，馬藥和補充品領域仍有望實現成長。

主要市場統計
基準年[2023] 93052萬美元
預測年份 [2024] 98349萬美元
預測年份 [2030] 1,379.52 百萬美元
複合年成長率（%） 5.78%

市場動態：揭示快速發展的馬藥和補充品市場的關鍵市場洞察

馬藥品和補充品市場正在因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 提高對馬藥品和補充品產品的認知
    • 由於養馬者對有機產品的偏好，對草藥飼料、消化助劑和能量補充品的需求增加
    • 在賽馬和馬術領域擴大採用馬補充品
  • 市場限制因素
    • 關於藥物和補充品的嚴格規定
  • 市場機會
    • 更關注馬匹的整體健康和電解質補充品的廣泛使用
    • 新馬藥和補充品的開發
  • 市場問題
    • 對馬健康的副作用

波特的五力：駕馭馬藥和補充品市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解馬藥品和補充品市場的外部影響

外部宏觀環境因素在影響馬藥和補充品市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解馬藥品和補充品市場的競爭格局

馬藥品和補充品市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：馬藥品和補充品市場供應商的績效評估

FPNV 定位矩陣是評估馬藥品和補充品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製馬藥和補充品市場的成功之路

對於希望加強在全球市場的影響力的公司來說，對馬藥品和補充品市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高對馬藥品和補充品產品的認知
      • 有機產品越來越受到養馬者的青睞，對草藥飼料、消化助劑和能量補充品。
      • 賽馬和馬術領域更多地採用馬補充品
    • 抑制因素
      • 關於藥物和補充品的嚴格規定
    • 機會
      • 對馬匹整體健康的日益重視導致電解質補充品的廣泛使用
      • 新馬藥和補充品的開發
    • 任務
      • 對馬健康的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章馬藥品和補充品市場：依產品

  • 介紹
  • 藥品
    • 發炎（藥
    • 抗潰瘍藥
    • 鎮靜劑和鎮靜劑
  • 補充品
    • 關節補充品
    • 維生素和礦物質

第7章馬藥品和補充品市場：按分銷管道

  • 介紹
  • 藥局
  • 動物醫院

第8章北美和南美馬藥品和補充品市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太馬藥及補充品市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的馬藥品和補充品市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Alltech
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Dechra Veterinary Products Limited
  • Elanco Animal Health Incorporated
  • Equineproducts-uk Ltd.
  • Lallemand, Inc.
  • Merck & Co., Inc.
  • Purina Animal Nutrition LLC
  • Thermo Fisher Scientific Inc.
  • Vetoquinol USA
  • Virbac
  • Zoetis Inc.
Product Code: MRR-4348D129FACA

The Equine Pharmaceuticals & Supplements Market was valued at USD 930.52 million in 2023, expected to reach USD 983.49 million in 2024, and is projected to grow at a CAGR of 5.78%, to USD 1,379.52 million by 2030.

The equine pharmaceuticals and supplements market encompasses a diverse range of products that are formulated specifically for horses, including medications, nutritional supplements, and veterinary treatments aimed at maintaining and enhancing equine health. The necessity of these products emerges primarily from the extensive participation of equines in sports, agriculture, and leisure activities, which demands optimum health and performance. Applications range from providing essential nutrients and managing joint and bone health to treating specific medical conditions. Veterinarians, equine therapists, breeders, and horse owners represent the primary end-users, underlining the importance of these products in the equine industry. Market growth is strongly influenced by factors such as increasing awareness regarding horse health, the rising prevalence of equine diseases, and a growing inclination towards natural ingredients and formulations. Moreover, the expanding equestrian sports industry adds significant impetus to market demand. However, the market faces challenges such as fluctuating ingredient costs, stringent regulatory landscapes, and the need for comprehensive research to validate product efficacy. Innovations in this domain could focus on developing advanced delivery systems for supplements, leveraging biotechnological advancements for novel therapeutics, and utilizing data analytics for personalized equine health management. R&D efforts could also explore tailored formulations for specific breeds or conditions. Companies venturing into this space should consider strategic partnerships or collaborations for enhanced distribution and expanded product lines targeting niche markets. Potential opportunities exist within the untapped regions where equine sports are gaining traction, requiring companies to strategize market penetration and consumer education effectively. The market is characterized by both established firms and emerging players, fostering a competitive environment that necessitates consistent innovation and adherence to quality. Despite challenges, the equine pharmaceuticals and supplements sector is poised for growth, driven by continuous demand for specialized and sustainable solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 930.52 million
Estimated Year [2024] USD 983.49 million
Forecast Year [2030] USD 1,379.52 million
CAGR (%) 5.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Equine Pharmaceuticals & Supplements Market

The Equine Pharmaceuticals & Supplements Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness about equine pharmaceuticals and supplements products
    • Rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products
    • Growing adoption of equine supplements in horse racing and equestrian sectors
  • Market Restraints
    • Stringent regulations regarding the pharmaceutical products and supplements
  • Market Opportunities
    • Growing emphasis on overall equine health and wellness, and extensively use of electrolyte supplements
    • Development of new equine pharmaceuticals & supplements
  • Market Challenges
    • Side effects on the health of equine

Porter's Five Forces: A Strategic Tool for Navigating the Equine Pharmaceuticals & Supplements Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Equine Pharmaceuticals & Supplements Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Equine Pharmaceuticals & Supplements Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Equine Pharmaceuticals & Supplements Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Equine Pharmaceuticals & Supplements Market

A detailed market share analysis in the Equine Pharmaceuticals & Supplements Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Equine Pharmaceuticals & Supplements Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Equine Pharmaceuticals & Supplements Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Equine Pharmaceuticals & Supplements Market

A strategic analysis of the Equine Pharmaceuticals & Supplements Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Equine Pharmaceuticals & Supplements Market, highlighting leading vendors and their innovative profiles. These include Alltech, Bayer AG, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Dechra Veterinary Products Limited, Elanco Animal Health Incorporated, Equineproducts-uk Ltd., Lallemand, Inc., Merck & Co., Inc., Purina Animal Nutrition LLC, Thermo Fisher Scientific Inc., Vetoquinol USA, Virbac, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Equine Pharmaceuticals & Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Pharmaceutical and Supplement. The Pharmaceutical is further studied across Anti-Inflammatory, Anti-Ulcer Drugs, and Sedative & Tranquilizer. The Supplement is further studied across Joint Supplements and Vitamins & Minerals.
  • Based on Distribution Channel, market is studied across Drug Stores and Veterinary Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness about equine pharmaceuticals and supplements products
      • 5.1.1.2. Rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products
      • 5.1.1.3. Growing adoption of equine supplements in horse racing and equestrian sectors
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations regarding the pharmaceutical products and supplements
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing emphasis on overall equine health and wellness, and extensively use of electrolyte supplements
      • 5.1.3.2. Development of new equine pharmaceuticals & supplements
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects on the health of equine
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Equine Pharmaceuticals & Supplements Market, by Product

  • 6.1. Introduction
  • 6.2. Pharmaceutical
    • 6.2.1. Anti-Inflammatory
    • 6.2.2. Anti-Ulcer Drugs
    • 6.2.3. Sedative & Tranquilizer
  • 6.3. Supplement
    • 6.3.1. Joint Supplements
    • 6.3.2. Vitamins & Minerals

7. Equine Pharmaceuticals & Supplements Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Drug Stores
  • 7.3. Veterinary Hospitals

8. Americas Equine Pharmaceuticals & Supplements Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Equine Pharmaceuticals & Supplements Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Equine Pharmaceuticals & Supplements Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alltech
  • 2. Bayer AG
  • 3. Boehringer Ingelheim International GmbH
  • 4. Cargill, Incorporated
  • 5. Ceva Sante Animale
  • 6. Dechra Veterinary Products Limited
  • 7. Elanco Animal Health Incorporated
  • 8. Equineproducts-uk Ltd.
  • 9. Lallemand, Inc.
  • 10. Merck & Co., Inc.
  • 11. Purina Animal Nutrition LLC
  • 12. Thermo Fisher Scientific Inc.
  • 13. Vetoquinol USA
  • 14. Virbac
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET RESEARCH PROCESS
  • FIGURE 2. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY ANTI-ULCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SEDATIVE & TRANQUILIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY JOINT SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY SUPPLEMENT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023